ConductScience.org, home

Paper23878286

Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.

Chung WJ and 4 others. Radiology, 2013. Cited by 77 papers, by iCite.

Cite this record

ConductScience Library. Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging. Papers, record 23878286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23878286

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.
PubMed
Journal
Radiology
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
77
iCite
Relative citation ratio, by iCite
3.33
iCite
Revised in PubMed
2022-11-02
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chung WJWon Jung
2Kim HSHo Sung
3Kim NNamkug
4Choi CGChoong Gon
5Kim SJSang Joon

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlioblastomaMajor topic
Magnetic Resonance ImagingMajor topic
Neoplasm Recurrence, LocalMajor topic
Adult
Aged
Area Under Curve
Contrast Media
Diagnosis, Differential
Female
Humans
Image Interpretation, Computer-Assisted
Male
Middle Aged
Radiation Injuries
Retrospective Studies

Source PubMed

Download CSV of topics

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.

PMIDTitleJournalYearIn PapersSource
42128847A Novel MR Cine Sialography Technique for Evaluating Salivary Gland Function: Correlation with Unstimulated and Stimulated Saliva Volumes.Magn Reson Med Sci2026https://conductscience.org/library/papers/42128847PubMed
41621439Dynamic Contrast Enhanced-Magnetic Resonance Fingerprinting (DCE-MRF) Improves Detection of Induced Vascular Perfusion Reduction in a Mouse Breast Cancer Model.Magn Reson Med2026https://conductscience.org/library/papers/41621439PubMed
41489694Time-dependent diffusion-weighted imaging assessment of tumor grading and isocitrate dehydrogenase genotypes in adult-type diffuse gliomas.Jpn J Radiol2026https://conductscience.org/library/papers/41489694PubMed
40785853Whole-tumor histogram analysis of synthetic MRI for discriminating benign from malignant sinonasal tumors: correlations with histopathologic factors.Quant Imaging Med Surg2025https://conductscience.org/library/papers/40785853PubMed
39795566Quantitative Physiologic MRI Combined with Feature Engineering for Developing Machine Learning-Based Prediction Models to Distinguish Glioblastomas from Single Brain Metastases.Diagnostics (Basel)2024https://conductscience.org/library/papers/39795566PubMed
39502470
Distinction of pseudoprogression from true progression in glioblastomas using machine learning based on multiparametric magnetic resonance imaging and O6-methylguanine-methyltransferase promoter methylation status.
Neurooncol Adv2024https://conductscience.org/library/papers/39502470PubMed
39429559The value of predicting neoadjuvant chemotherapy early efficacy in nasopharyngeal carcinoma based on amide proton transfer imaging and diffusion weighted imaging.Quant Imaging Med Surg2024https://conductscience.org/library/papers/39429559PubMed
38791921Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma.Cancers (Basel)2024https://conductscience.org/library/papers/38791921PubMed
38037172Differentiating primary central nervous system lymphoma from glioblastoma by time-dependent diffusion using oscillating gradient.Cancer Imaging2023https://conductscience.org/library/papers/38037172PubMed
37553578Differentiating brain metastasis from glioblastoma by time-dependent diffusion MRI.Cancer Imaging2023https://conductscience.org/library/papers/37553578PubMed
37492665Conventional and Advanced Imaging Techniques in Post-treatment Glioma Imaging.Front Radiol2022https://conductscience.org/library/papers/37492665PubMed
37016104Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy.Insights Imaging2023https://conductscience.org/library/papers/37016104PubMed
36698156The utility of texture analysis based on quantitative synthetic magnetic resonance imaging in nasopharyngeal carcinoma: a preliminary study.BMC Med Imaging2023https://conductscience.org/library/papers/36698156PubMed
36380750Value of DWI Combined with Magnetic Resonance Spectroscopy in the Differential Diagnosis between Recurrent Glioma and Radiation Injury: A Meta-Analysis.Int J Clin Pract2022https://conductscience.org/library/papers/36380750PubMed
36185045Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression.Quant Imaging Med Surg2022https://conductscience.org/library/papers/36185045PubMed
35954435Tumor Progression and Treatment-Related Changes: Radiological Diagnosis Challenges for the Evaluation of Post Treated Glioma.Cancers (Basel)2022https://conductscience.org/library/papers/35954435PubMed
35907033Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [18F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma.Eur J Nucl Med Mol Imaging2022https://conductscience.org/library/papers/35907033PubMed
35185410Follow-Up of High-Grade Glial Tumor; Differentiation of Posttreatment Enhancement and Tumoral Enhancement by DCE-MR Perfusion.Contrast Media Mol Imaging2022https://conductscience.org/library/papers/35185410PubMed
35084518Response prediction of vestibular schwannoma after gamma-knife radiosurgery using pretreatment dynamic contrast-enhanced MRI: a prospective study.Eur Radiol2022https://conductscience.org/library/papers/35084518PubMed
34694565Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.J Neurooncol2022https://conductscience.org/library/papers/34694565PubMed

See all 58 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23878286

GET https://conductscience.org/api/papers/v1/23878286/cited_by?page=2